Dr Eddie La Marca
Honorary (Fellow)
Department of Medical Biology (WEHI)
19 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening
DOI: 10.1038/s41467-025-56282-22025
Journal article
RhoGEF2 overexpression induces cell competition dependent on Ptp10D, Crumbs and the Hippo signaling pathway
DOI: 10.1242/jcs.2643772025
Journal article
Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of Cancer
DOI: 10.1146/annurev-cancerbio-062624-1041492024
Journal article
Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy
DOI: 10.1016/j.devcel.2024.06.0182024
Journal article
Mouse models to investigate in situ cell fate decisions induced by p53
DOI: 10.1038/s44318-024-00189-z2024
Journal article
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
DOI: 10.1016/j.ccell.2024.04.0042024
Journal article
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses
DOI: 10.1038/s41418-023-01249-3
RECENT SCHOLARLY WORKS
2024
Journal article
The Drosophila tumour suppressor Lgl and Vap33 activate the Hippo pathway through a dual mechanism
DOI: 10.1242/jcs.2619172023
Journal article
BCL-W makes only minor contributions to MYC-driven lymphoma development
DOI: 10.1038/s41388-023-02804-52023
Journal article
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs
DOI: 10.1038/s41418-023-01117-0